中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2013年
10期
560-563
,共4页
苏玉亮%张寰%曲金力%钱碧云
囌玉亮%張寰%麯金力%錢碧雲
소옥량%장환%곡금력%전벽운
肺癌%表皮生长因子受体%miR-335%生物信息学
肺癌%錶皮生長因子受體%miR-335%生物信息學
폐암%표피생장인자수체%miR-335%생물신식학
lung carcinoma%EGFR%miR-335%bioinformatics
目的:通过筛选肺癌组织中表皮生长因子受体(epidermal growth factor receptor,EGFR)突变差异表达的microRNAs (miRs),并对其进行靶基因预测及功能的生物信息学分析,以期为miR与EGFR在肺癌中潜在的相互作用机制研究奠定基础.方法:利用TaqMan低密度芯片(TaqMan Low Density Array,TLDA)在4对肺癌组织中筛选EGRF突变差异表达的miRs.应用miRan?da、PicTar和TargetScan数据库进行靶基因预测,并通过DAVID数据库对预测的靶基因进行Gene Ontology(GO)分析和KEGG信号转导通路富集分析.结果:miR-335在配对肺癌组织样本间差异表达值ΔΔCt(cycle threshold)的绝对值均>1,预测其有57个靶基因,功能主要集中于通道调节因子活性等8类分子(P<0.05)和RNA代谢调节等22类生物学过程(P<0.05).分析结果未提示有显著富集的细胞组分和信号转导通路(P>0.05).结论:本研究虽然未明确提示miR-335与EGFR具有直接作用,但是其参与的调控网络可能与EGFR具有密切联系.
目的:通過篩選肺癌組織中錶皮生長因子受體(epidermal growth factor receptor,EGFR)突變差異錶達的microRNAs (miRs),併對其進行靶基因預測及功能的生物信息學分析,以期為miR與EGFR在肺癌中潛在的相互作用機製研究奠定基礎.方法:利用TaqMan低密度芯片(TaqMan Low Density Array,TLDA)在4對肺癌組織中篩選EGRF突變差異錶達的miRs.應用miRan?da、PicTar和TargetScan數據庫進行靶基因預測,併通過DAVID數據庫對預測的靶基因進行Gene Ontology(GO)分析和KEGG信號轉導通路富集分析.結果:miR-335在配對肺癌組織樣本間差異錶達值ΔΔCt(cycle threshold)的絕對值均>1,預測其有57箇靶基因,功能主要集中于通道調節因子活性等8類分子(P<0.05)和RNA代謝調節等22類生物學過程(P<0.05).分析結果未提示有顯著富集的細胞組分和信號轉導通路(P>0.05).結論:本研究雖然未明確提示miR-335與EGFR具有直接作用,但是其參與的調控網絡可能與EGFR具有密切聯繫.
목적:통과사선폐암조직중표피생장인자수체(epidermal growth factor receptor,EGFR)돌변차이표체적microRNAs (miRs),병대기진행파기인예측급공능적생물신식학분석,이기위miR여EGFR재폐암중잠재적상호작용궤제연구전정기출.방법:이용TaqMan저밀도심편(TaqMan Low Density Array,TLDA)재4대폐암조직중사선EGRF돌변차이표체적miRs.응용miRan?da、PicTar화TargetScan수거고진행파기인예측,병통과DAVID수거고대예측적파기인진행Gene Ontology(GO)분석화KEGG신호전도통로부집분석.결과:miR-335재배대폐암조직양본간차이표체치ΔΔCt(cycle threshold)적절대치균>1,예측기유57개파기인,공능주요집중우통도조절인자활성등8류분자(P<0.05)화RNA대사조절등22류생물학과정(P<0.05).분석결과미제시유현저부집적세포조분화신호전도통로(P>0.05).결론:본연구수연미명학제시miR-335여EGFR구유직접작용,단시기삼여적조공망락가능여EGFR구유밀절련계.
This study measured the expression of microRNAs (miRs) between paired lung cancer tissues with and without epidermal growth factor receptor (EGFR) mutation and then bioinformatically predicted the target genes. The functions of miRs were analyzed to provide basis for the potential regulator mechanism between miR and EGFR in the future. Methods: The TaqMan low-density array was applied to identify the miRs differently expressed between 4 paired lung cancer tissues with and without EGFR mutation. The target genes of miR-335 were screened using miRanda, PicTar, and TargetScan databases. Subsequent bioinformatics analysis of these target genes was performed by gene ontology (GO) and KEGG pathway analyses using the DAVID database. Results:The miR-335 expression between paired lung cancer tissues was different. A total of 57 predicted target genes of miR-335 were found. The gene set was mainly located in eight molecular functions (P<0.05), such as channel regulator activity, among others, and 22 biological processes (P<0.05), such as regulation of RNA metabolic process, among others. GO cellular component and KEGG pathway analyses found no significant result. Conclusion: Results showed that miR-335 had no direct effect on EGFR. However, the regulatory network involving miR-335 might be closely associated with EGFR.